Vincent Perrone | Director of Corporate Communications |
Jeff Riley | CEO |
Steve Shallcross | CFO |
Katherine Xu | William Blair |
Keith Markey | Griffin Securities |
Good evening, and welcome to the Synthetic Biologics 2017 Third Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director of Corporate Communications at Synthetic Biologics. Vincent please go ahead.